Literature DB >> 24724745

Belgian recommendations on ANA, anti-dsDNA and anti-ENA antibody testing.

M Van Blerk, X Bossuyt, R Humbel, A Mewis, G Servais, J P Tomasi, C Van Campenhout, L Van Hoovels, M Vercammen, J Damoiseaux, W Coucke, P Van de Walle.   

Abstract

Autoantibodies to nuclear antigens, i.e. antinuclear antibodies (ANA), antibodies to double-stranded DNA (dsDNA) and extractable nuclear antigens (ENA), are useful as diagnostic markers for a variety of autoimmune diseases. In March 2010, the Belgian national External Quality Assessment Scheme sent a questionnaire on ANA, anti-dsDNA and anti-ENA antibody testing designed by the Dutch EASI (European Autoimmunity Standardization Initiative) team, to all clinical laboratories performing ANA testing. Virtually all laboratories completed the questionnaire (97·7%, 127/130). This paper discusses the results of this questionnaire and provides valuable information on the state-of-the-art of ANA, anti-dsDNA and anti-ENA antibody testing as practiced in the Belgian laboratories. In addition, this work presents practical recommendations developed by the members of the advisory board of the scheme as a result of the outcome of this study.

Entities:  

Keywords:  Anti-ENA antibodies,; Anti-dsDNA antibodies,; Antinuclear antibodies,; External quality assessment; Recommendations,

Mesh:

Substances:

Year:  2014        PMID: 24724745     DOI: 10.1179/2295333714Y.0000000010

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  7 in total

1.  How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative.

Authors:  Carlos Alberto von Mühlen; Ignacio Garcia-De La Torre; Maria Infantino; Jan Damoiseaux; Luis E C Andrade; Orlando Gabriel Carballo; Karsten Conrad; Paulo Luiz Carvalho Francescantonio; Marvin J Fritzler; Manfred Herold; Werner Klotz; Wilson de Melo Cruvinel; Tsuneyo Mimori; Minoru Satoh; Lucile Musset; Edward K L Chan
Journal:  Immunol Res       Date:  2021-10-09       Impact factor: 2.829

2.  Current practice in laboratory diagnostics of autoimmune diseases in Croatia. 
Survey of the Working group for laboratory diagnostics of autoimmune diseases of the Croatian Society of Medical Biochemistry and Laboratory Medicine.

Authors:  Andrea Tešija Kuna; Lovorka Đerek; Ana Kozmar; Vedrana Drvar
Journal:  Biochem Med (Zagreb)       Date:  2016-10-15       Impact factor: 2.313

3.  ANA IIF Automation: Moving towards Harmonization? Results of a Multicenter Study.

Authors:  Stefanie Van den Bremt; Sofie Schouwers; Marjan Van Blerk; Lieve Van Hoovels
Journal:  J Immunol Res       Date:  2017-02-21       Impact factor: 4.818

Review 4.  Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine.

Authors:  Andrea Tešija Kuna; Lovorka Đerek; Vedrana Drvar; Ana Kozmar; Katarina Gugo
Journal:  Biochem Med (Zagreb)       Date:  2021-04-15       Impact factor: 2.313

5.  Positioning of myositis-specific and associated autoantibody (MSA/MAA) testing in disease criteria and routine diagnostic work-up.

Authors:  Carolien Bonroy; Yves Piette; Yves Allenbach; Xavier Bossuyt; Jan Damoiseaux
Journal:  J Transl Autoimmun       Date:  2022-02-11

6.  International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results.

Authors:  Jan Damoiseaux; Carlos A von Mühlen; Ignacio Garcia-De La Torre; Orlando Gabriel Carballo; Wilson de Melo Cruvinel; Paulo Luiz Carvalho Francescantonio; Marvin J Fritzler; Manfred Herold; Tsuneyo Mimori; Minoru Satoh; Luis E C Andrade; Edward K L Chan; Karsten Conrad
Journal:  Auto Immun Highlights       Date:  2016-01-30

7.  Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.

Authors:  Concepción González Rodríguez; Sandra Fuentes Cantero; Antonio Pérez Pérez; Francisco Javier Vázquez Barbero; Antonio León Justel
Journal:  J Clin Lab Anal       Date:  2021-08-04       Impact factor: 2.352

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.